Duramed Research

CompanyUnited States

Duramed Research develops 2 assets, the furthest in phase 3, no development reported (DR-1011 in contraception). Based in the United States.

2
Assets
Furthest stage
Phase 3, no development reported
11
Trials
0
Signals

Pipeline

2
  • DR-1011

    Phase 3, no development reported, contraception, bone mineral density (Phase 2)

  • DR-1031

    Phase 3, no development reported, contraception, bone mineral density (Phase 2)

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials11
  • Similar companies6

Intelligence